#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3855949	B	Displacement of [3H]-RX 821002 from alpha2-AR in Sprague-Dawley rat brain membranes after 30 mins by liquid scintillation counting	Rattus norvegicus	9		cell membrane format	Scientific Literature
2.	ALA3855950	B	Displacement of [125I]-p-iodoclonidine from I1 receptor imidazoline binding site in Sprague-Dawley rat kidney cell membranes after 30 mins by liquid scintillation counting	Rattus norvegicus	9		cell-based format	Scientific Literature
3.	ALA3855951	B	Displacement of [3H]-2-BFI from I2 receptor imidazoline binding site in Sprague-Dawley rat brain membranes after 30 mins by liquid scintillation counting	Rattus norvegicus	9		cell membrane format	Scientific Literature
4.	ALA3855953	B	Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis	Homo sapiens	5		cell-based format	Scientific Literature
5.	ALA3855954	B	Agonist activity at human alpha2c-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis	Homo sapiens	5		cell-based format	Scientific Literature
6.	ALA3855956	B	Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis relative to (-)-noradrenaline	Homo sapiens	5		cell-based format	Scientific Literature
7.	ALA3855957	B	Agonist activity at human alpha2c-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis relative to (-)-noradrenaline	Homo sapiens	5		cell-based format	Scientific Literature
8.	ALA3855958	B	Antagonist activity at human alpha2a-AR expressed in CHO cells assessed as inhibition of (-)-noradrenaline-induced acidification rate after 240 mins by cytosensor microphysiometric analysis	Homo sapiens	4		cell-based format	Scientific Literature
9.	ALA3855959	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated jumping at 5 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA3855960	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated jumping at 10 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	2		organism-based format	Scientific Literature
11.	ALA3855961	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated rearing frequency at 5 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA3855962	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated forepaw tremor frequency at 5 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA3855963	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated teeth chattering frequency at 5 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	2		organism-based format	Scientific Literature
14.	ALA3855964	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated rearing frequency at 10 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	2		organism-based format	Scientific Literature
15.	ALA3855965	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated forepaw tremor frequency at 10 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	2		organism-based format	Scientific Literature
16.	ALA3855966	F	Reduction in morphine dependence expression in CD1 mouse assessed as inhibition of naloxone-precipitated teeth chattering frequency at 10 mg/kg, ip administered acutely 15 mins prior to naloxone challenge relative to control	Mus musculus	2		organism-based format	Scientific Literature
17.	ALA3855967	F	Reduction in morphine dependence acquisition in CD1 mouse assessed as inhibition of naloxone-precipitated jumping at 5 to 10 mg/kg, ip administered 15 mins prior to each morphine challenge relative to control	Mus musculus	1		organism-based format	Scientific Literature
18.	ALA3855968	F	Reduction in morphine dependence acquisition in CD1 mouse assessed as inhibition of naloxone-precipitated rearing frequency at 5 to 10 mg/kg, ip administered 15 mins prior to each morphine challenge relative to control	Mus musculus	1		organism-based format	Scientific Literature
19.	ALA3855969	F	Reduction in morphine dependence acquisition in CD1 mouse assessed as inhibition of naloxone-precipitated forepaw tremor frequency at 5 to 10 mg/kg, ip administered 15 mins prior to each morphine challenge relative to control	Mus musculus	1		organism-based format	Scientific Literature
20.	ALA3855970	F	Reduction in morphine dependence acquisition in CD1 mouse assessed as inhibition of naloxone-precipitated teeth chattering frequency at 5 to 10 mg/kg, ip administered 15 mins prior to each morphine challenge relative to control	Mus musculus	1		organism-based format	Scientific Literature